Empagliflozin in Patients With Heart Failure Efficacy and Safety Concerns Across Kidney Risk Categories

被引：0
|
作者：
Ohshiro, Yuzuru [1 ]
机构：
[1] Omoromachi Med Ctr, Dept Internal Med, Uenoya 1-3-1, Naha, Okinawa 9010011, Japan
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2023年 / 82卷 / 15期
关键词：
D O I：
10.1016/j.jacc.2023.06.052
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E133 / E133
页数：1
相关论文
共 50 条
  • [1] Efficacy of Empagliflozin in Patients With Heart Failure Across Kidney Risk Categories
    Butler, Javed
    Packer, Milton
    Siddiqi, Tariq Jamal
    Boehm, Michael
    Brueckmann, Martina
    Januzzi, James L.
    Verma, Subodh
    Gergei, Ingrid
    Iwata, Tomoko
    Wanner, Christoph
    Ferreira, Joao Pedro
    Pocock, Stuart J.
    Filippatos, Gerasimos
    Anker, Stefan D.
    Zannad, Faiez
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (19) : 1902 - 1914
  • [2] Efficacy of empagliflozin in patients with heart failure according to baseline KDIGO risk categories findings from the EMPEROR-Pooled
    Butler, J.
    EUROPEAN HEART JOURNAL, 2022, 43 : 1064 - 1064
  • [3] Efficacy and Safety of Empagliflozin in Hospitalized Heart Failure Patients: Main Results From the EMPULSE Trial
    Voors, Adriaan A.
    Angermann, Christiane E.
    Teerlink, John R.
    Collins, Sean P.
    Kosiborod, Mikhail N.
    Biegus, Jan
    Ferreira, Joao P.
    Nassif, Michael E.
    Psotka, Mitchell A.
    Tromp, Jasper
    Brueckmann, Martina
    Blatchford, Jon
    Salsali, Afshin
    Ponikowski, Piotr
    CIRCULATION, 2021, 144 (25) : E572 - E572
  • [4] Clinical Efficacy and Safety of Empagliflozin in Patients with Acute Heart Failure from the First Day of Hospitalization
    Golubovskaya, D. P.
    Karetnikova, V. N.
    Osokina, A. B.
    Oleinik, I. P.
    Barbarash, O. L.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2023, 19 (02) : 126 - 133
  • [5] Empagliflozin improves kidney outcomes in patients with heart failure and CKD
    Carney, Ellen F.
    NATURE REVIEWS NEPHROLOGY, 2021, 17 (01) : 14 - 14
  • [6] Empagliflozin improves kidney outcomes in patients with heart failure and CKD
    Ellen F. Carney
    Nature Reviews Nephrology, 2021, 17 : 14 - 14
  • [7] Efficacy and Safety of Empagliflozin Continuation in Patients with Type 2 Diabetes Hospitalised for Acute Decompensated Heart Failure
    Perez-Belmonte, Luis M.
    Ricci, Michele
    Sanz-Canovas, Jaime
    Millan-Gomez, Mercedes
    Osuna-Sanchez, Julio
    Isabel Ruiz-Moreno, M.
    Bernal-Lopez, M. Rosa
    Lopez-Carmona, Maria D.
    Jimenez-Navarro, Manuel
    Gomez-Doblas, Juan J.
    Lara, Jose P.
    Gomez-Huelgas, Ricardo
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (16)
  • [8] Safety and Efficacy of Empagliflozin in Hospitalized Patients With Acute Heart Failure: A Systematic Review and Meta-Analysis
    Shuja, Muhammad Hamza
    Moeed, Abdul
    Shakil, Firzah
    Shakil, Shajia
    Farooq, Abeera
    Ragupathi, Ashwin
    Abid, Mishal
    Imran, Hamza
    Qaiser, Faiq
    Hasan, Minhal
    Edhi, Maliha
    Khemmane, Zoya
    Alam, Mahboob
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (18) : B147 - B147
  • [9] EFFECTS OF SACUBITRIL/VALSARTAN IN PATIENTS WITH HEART FAILURE ACROSS THE SPECTRUM OF KIDNEY RISK
    Chatur, Safia
    Claggett, Brian
    Mc Causland, Finnian
    Packer, Milton
    Desai, Akshay S.
    Rouleau, Jean L.
    Zile, Michael R.
    Lefkowitz, Martin
    McMurray, John J. V.
    Solomon, Scott D.
    Vaduganathan, Muthiah
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 4605 - 4605
  • [10] In chronic HF, empagliflozin reduced a composite of CV death or HF hospitalization across kidney risk categories
    Ziaolhagh, Ali
    Molony, Donald A.
    ANNALS OF INTERNAL MEDICINE, 2023, 176 (09) : JC101 - JC101
12345